Increased sST2 may worsen myocardial injury and infection by obstructing the cardioprotective and immunomodulatory functions of the IL-33/ST2l pathway, thereby creating a detrimental “inflammation-infection” cycle (33–35). This evidence concerns the gene IL33 and infection.